Induction of differentiation and mineralization in rat tooth germ cells on PVA
through inhibition of ERK1/2
Rung-Shu Chen
a
, Min-Huey Chen
b
,c
,**
, Tai-Horng Young
a
,*
aInstitute of Biomedical Engineering, College of Medicine and College of Engineering, National Taiwan University, #1, Sec. 1, Jen-Ai Road, Taipei 100, Taiwan bDepartment of Dentistry, National Taiwan University Hospital, Taipei 100, Taiwan
cSchool of Dentistry, College of Medicine, National Taiwan University, Taipei 100, Taiwan
a r t i c l e
i n f o
Article history: Received 23 July 2008 Accepted 30 September 2008 Available online 9 November 2008 Keywords:
Poly(vinyl alcohol) (PVA) Tooth germ (TG) cells Differentiation Mineralization
Extracellular signaling-regulated kinase1/2 (ERK1/2)
a b s t r a c t
Poly(vinyl alcohol) (PVA) has been widely used in the field of biomedical applications because of its hydrophilic properties for desired functions. Nonetheless, the role of PVA in tooth germ (TG) cell differentiation and mineralization has seldom been explored. To test the capacity of PVA in regulating TG cell differentiation and mineralization, TG cells obtained from 4-day-old Wistar rats were cultured on the PVA substrate. It was found that PVA was able to promote TG cell exhibiting high levels of alkaline phosphatase (ALP) activity, mineralization, and mRNA expression of osteocalcin (OCN), osteopontin (OPN), dentin matrix protein 1 (DMP1) and enamelin. Even when the additives routinely administrated in the differentiation medium such as dexamethasone,
b-glycerophosphate and ascorbic acid were
removed from the culture system, PVA itself still stimulated TG cells with the differentiation and mineralization ability. By showing the direct suppression of extracellular signaling-regulated kinase1/2 (ERK1/2) of TG cells treated with U0126, known to suppress the activation of ERK1/2, and significant synergistic effects between PVA and U0126, we demonstrated the suppression of ERK1/2 pathway is one of the effects of PVA-promoted TG cell differentiation and mineralization. Taken together, this study demonstrated a novel role of PVA in promoting the differentiation and mineralization of TG cells through ERK1/2 acting as a negative regulator.Ó 2008 Elsevier Ltd. All rights reserved.
1. Introduction
The tooth germ (TG), sometimes called the tooth bud,
contains a heterogeneous population of cells including
amelo-blasts, odontoblasts and dental pulp cells. During tooth
devel-opment, TG cell differentiation and mineralization proceed
synchronously eventually forming a tooth
[1]
. Thus, similar to
other osteoblast-like cells
[2–4]
, TG cells also can serve as
a model to elucidate the cell differentiation and mineralization
in vitro and to determine the effects of growth factors,
cyto-kines, and mechanical stimulus implicated in cell differentiation
and mineralization.
We recently reported that the adhesion and proliferation of
TG cells were sensitive to changes in surface hydrophilic
prop-erties of biomaterial
[5]
. Especially, the very hydrophilic
bioma-terial poly(vinyl alcohol) (PVA) could maintain TG cells with
a three-dimensional spherical structure, resembling in vivo
physiological condition. It is well known that cell behavior on
biomaterial is crucial to many biomedical applications, yet the
molecular pathways responsible for converting PVA signals into
TG cell responses are still being elucidated. Therefore, the
purpose of the study was to investigate the effect of PVA on TG
cell differentiation and mineralization, and the possible signaling
pathway involved in regulating TG cell change in response to
PVA biomaterial.
The
mitogen-activated
protein
kinase
(MAPK)
signaling
pathway is tightly related to the regulation of cell proliferation,
differentiation, motility and death
[6,7]
. Three central elements of
the MAPK family have been identified in mammalian cells, referred
to as extracellular signal-regulated kinase1/2 (ERK1/2), p38 kinase,
and c-Jun-N terminal kinase (JNK)
[8–10]
. This study made use of
Western blot analysis to examine the role of individual MAPK
pathway in enhancing alkaline phosphatase (ALP) activity and
mineralization of TG cells by blocking the pathway using specific
inhibitor. To our knowledge, TG cells were not employed to
examine how MAPK signaling pathways can be triggered by PVA.
Our findings show PVA is an effective substrate that promotes TG
cell differentiation and mineralization and the ERK1/2 dependent
*Corresponding author. Tel.: þ886 2 2312 3456; fax: þ886 2 2394 0049.**Corresponding author. Department of Dentistry, National Taiwan University Hospital, Taipei 100, Taiwan.
E-mail address:[email protected](T.-H. Young).
Contents lists available at
ScienceDirect
Biomaterials
j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / b i o m a t e r i a l s
0142-9612/$ – see front matter Ó 2008 Elsevier Ltd. All rights reserved. doi:10.1016/j.biomaterials.2008.09.054
pathway plays an important role in negatively mediating function
of TG cells.
2. Materials and methods 2.1. Preparation of PVA substrate
A 5 wt% solution of PVA (Chemika Fluka, MW ¼ 72,000 g/mol, Switzerland) was prepared by dissolving PVA in distilled water at 95C. For preparing PVA-coated
wells, 140ml of PVA solution was added into 24-welled tissue culture polystyrene (TCPS) plates (Costar, USA). The solution was then allowed to dry at 60C for 24 h to
form a thin membrane. Before cell culture, the PVA-coated wells were sterilized in 70% alcohol overnight and rinse extensively with phosphate buffered saline (PBS). As controls, uncoated TCPS wells were treated by the same way as PVA-coated wells. 2.2. Cell culture
The animal study was performed according to a protocol approved by the Review Committee of College of Medicine, National Taiwan University. The method for isolating TG cells from rat mandibular molar TG was described previously[5]. In brief, rat mandibular molar TG was removed from 4-day-old Wistar rats using the explant outgrowth technique without collagenase treatment. Ten first molar TGs in total were isolated from five rats from both sides of lower jaws of each rat. The TGs were placed in PBS and then were cut into small fragments about 1 mm3in size, in
which the TG cells were released. Subsequently, the excised fragments of TG and released cells were placed into a 15 ml centrifuge tube and centrifuged at 900 rpm for 5 min. After removal of the upper layer solution, cells with tissue fragments were mixed with 10 ml Dulbecco’ s modified Eagle medium (DMEM, Chemicon, USA) supplemented with 10% fetal calf serum (Gibco-RBL Life Technologies, UK), antibi-otic/antimycotic (penicillin G sodium 100 U/ml, streptomycin 100 g/ml, amphoter-icin B 0.25 g/ml, Gibco-BRL Life Technologies, UK) placed in a 100-mm cell culture dish (Costar, USA) and then cultured at 37C with 5% CO
2atmosphere in a
humid-ified incubator. TG cells released from the tissue fragments were grown to conflu-ence in approximately 6–8 days. At approximately 90% confluconflu-ence, tissue fragments were removed and used for another culture to release more TG cells, and sub-cultured in 100-mm cell culture dishes (Costar, USA) in fresh culture medium for another two weeks. The total number of cells obtained from each primary culture increased to approximately 1 108cells after 30 d in culture. In this work, TG cells used for the subsequent analysis were in the third passage and the medium was changed every 3 or 4 days.
2.3. ALP activity and mineralization assays
TG cells were cultured on PVA and TCPS at a density of 1 105cells/well for 1, 4
and 7 days in the above medium (regarded as the regular medium) and differenti-ation medium. The differentidifferenti-ation medium was supplemented with 100 nM dexa-methasone (Sigma, USA), 10 mMb-glycerophosphate (Sigma, USA) and 50mg/ml ascorbic acid (Sigma, USA). ALP activity was assayed using p-nitrophenylphosphate as a substrate following the method described previously[11]. The amount of p-nitrophenol produced was measured spectrophotometrically at 410 nm. The degree of mineralization was measured by staining with Alizarin Red S (ARS, Sigma, USA) as described by Ratisoontorn et al.[12]. Data were expressed as units of ARS released (1 unit ¼ 1 unit of optical density at 562 nm).
2.4. MAPK inhibition studies
The role of individual MAPK pathway in ALP activity and mineralization of TG cells was assessed by blocking the pathways using specific inhibitor. The ERK1/2 pathway was blocked with U0126 (Cell signaling, USA), which inhibits MEK1/2, an upstream molecule of the ERK phosphorylation cascade[13]. The p38 MAPK was specifically inhibited with SB203580 (Sigma, USA)[14]and JNK was inhibited with SP600125 (Sigma, USA)[15]. For assessing ALP activity, mineralization and gene expression of mineralization- and differentiation-related markers, TG cells were treated with or without inhibitor for 7 days. For Western blot analysis, TG cells were cultured in the differentiation medium for 4 h followed by treatment with inhibitor for 30 min.
2.5. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from TG cells by using Trizol (Invitrogen Life Technol-ogies, CA). The RNA (1mg) was reverse transcribed into first-strand cDNA using the iScript cDNA Synthesis kit (BIO-RAD, CA) for RT-PCR. The oligonucleotide RT-PCR primers for glyceraldehydes-3-phosphate (GAPDH), osteocalcin (OCN)[16], osteo-pontin (OPN)[17], dentin matrix protein 1 (DMP1) and enamelin are listed inTable 1. The PCR amplification was performed as follows: 32 cycles of denaturation at 94C
for 45 s, annealing for 45 s, and extension at 72C for 30 s. The amplified products
were analyzed by electrophoresis through 1.5% agarose gel containing 10mg/ml ethidium bromide, electrophoresed at 100 mV, and visualized on a UV trans-illuminator (Alpha Innotech, CA). All bands were scanned and analyzed using AlphaEase FC 4.0 software.
2.6. Western blot analysis
Cells were collected by gentle shaking of the wells and washed twice with PBS. Cell lysates were prepared with ice-cold lysis buffer (20 mMTris, pH 7.5, 150 mM NaCl, 1 mMEDTA, 10% glycerol, 1% Triton X-100, 1 mMNaF, 1 mMNa3VO4, 1:200
dilution of Protease Inhibitor Cocktail II; Calbiochem, Germany) for 30 min and then were sonicated at 4C for 15 s. Lysates were clarified by centrifugation at
14,000 rpm for 30 min at 4C and the resulting supernatant was saved for protein
analysis and Western blot analysis.
Protein concentration was measured by using the commercial protein assay reagent (Bio-Rad, CA). For Western blotting, the supernatant was added to an equal volume of Laemmli sample buffer (62.5 mMTris, pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol blue, 5% b-mercaptoethanol) and heated to 95C for 10 min. Proteins
(35mg total protein per lane) were separated by SDS-PAGE on 10% polyacrylamide gels and transferred onto PVDF membranes. The membranes were blocked with 5% non-fat milk in TBST buffer (Bio-Rad, CA), probed with primary rabbit antibodies against ERK1/2 and phospho-ERK1/2 (Cell Signaling, USA) at a dilution of 1:1000, and were incubated at 4C overnight. After washing, the blots were incubated with
anti-rabbit IgG-HRP conjugated secondary antibodies (Cell Signaling, USA) at a dilution of 1:5000 for 2–3 h. Finally, the proteins on the membranes were detected using the ECL Plus chemiluminescence system. Densitometric quantification of Western blots was done using AlphaEase FC 4.0 software.
2.7. Statistical analysis
Results are presented as the mean standard deviation (SD) of 3–5 independent cultures. Statistical significance was calculated using one-way analysis of variance (ANOVA) followed by post hoc procedure (Bonferoni analysis) (p < 0.005 was considered significant).
3. Results
In the present study, the very hydrophilic PVA substrate with
the air–water contact angle of 54.0 2.0
was used to maintain TG
cells with a three-dimensional spherical structure
[5]
. In addition,
monolayered TG cells on commercial TCPS with the air–water
contact angle of 62.7 2.4
[5]
was compared.
3.1. ALP activity and mineralization of TG cells on PVA and TCPS
To determine the effect of PVA on TG cell differentiation, ALP
activity, an early marker of odontoblasts differentiation
[18,19]
, and
ARS assay, a traditional approach for evaluating the calcium
depo-sition, were measured. In the culture system, cells were confluent on
TCPS due to the high seeding density and cells formed aggregates
suspending above PVA as reported previously
[5]
(data not shown).
Fig. 1
shows both TCPS and PVA expressed increasing levels of ALP
activity and ARS assay through 7 days of culture in the differentiation
medium. Nonetheless, TG cells grown on PVA showed greater
expression and significantly higher than those on TCPS at every time
point, regardless of ALP activity and ARS assay (p < 0.005).
Generally, culture medium was routinely changed and added
with dexamethasone,
b
-glycerophosphate and ascorbic acid, which
had been reported to be beneficial to differentiation of bone-like cells
[20]
. Therefore, to further explore whether PVA per se promoted the
differentiation and mineralization of TG cells, regular medium
without dexamethasone,
b
-glycerophosphate and ascorbic acid was
Table 1Oligonucleotide primer sequences utilized in the RT-PCR. Target cDNA Primer sequence (50–30) T hyb(C) Product size (bp) NCBI no. or Ref. GAPDH F ATGGGAAGCTGGTCATCAAC 51.8 375 NM017008 R CCACAGTCTTCTGAGTGGCA OCN F ATGAGGACCCTCTCTCTFCTC 56.3 293 [16] R GTGGTGCCATAGATGCGCTTG OPN F TCCAAGGAGTATAAGCAGCGGGCCA 58 200 [17] R CTCTTAGGGTCTAGGACTAGCTTCT DMP 1 F CTGGTATCAGGTCGGAAGAATC 55 499 NM206493 R CTCTCATTAGACTCGCTGTCAC Enamelin F CACCGTACCTTAGAGGCAATAC 54.8 463 NM000106 R GAGGTCCATGAAGGAAAGAGAG
prepared.
Fig. 2
shows TG cells grown on TCPS could not exhibit
significant effects on production of ALP and calcium accumulation in
the absence of differentiation medium. In contrast, PVA stimulation
still resulted in increased levels of ALP activity and ARS assay with
culture time. Similar to
Fig. 1
the expression of ALP activity and ARS
assay on PVA was always significantly higher than those on TCPS
during the culture period (p < 0.005). Therefore, TG cells could
exhibit high levels of ALP activity and mineralization on PVA,
regardless of the presence or absence of differentiation medium.
3.2. Effect of U0126 on TG cells differentiation and mineralization
It has been well documented that growth factor, cytokine, and
mechanical stimulation often induce changes in cell differentiation
and mineralization through the activation of MAPK, particularly
through ERK1/2 pathway
[21–24]
. Therefore, it is interesting to
investigate the effects of MAPK inhibitor on promoting or inhibiting
ALP activity and mineralization in TG cells. U0126, a widely used
inhibitor of MEK1/2, the upstream kinases of ERK1/2
[21]
was used
in this study.
Fig. 3
shows ALP activity and ARS assay of TG cells
grown on TCPS with differentiation medium in the presence of
U0126 ranging from 0 to 50
m
Mafter culture for 7 days. Clearly,
ERK1/2 inhibitor promoted TG cell differentiation in a
dose-dependent manner and its effect was significant for all
concentra-tion used (p < 0.005). In addiconcentra-tion, to address a possible involvement
of MAPKs other than ERK1/2 pathway, specific inhibitors for p38
and JNK were also examined. It was found that inhibition of p38 by
SB203580 (50
m
M) and of JNK by SP600125 (50
m
M) after culture for
7 days did not exhibit any effect on promoting ALP activity and
mineralization of TG cells (data not shown).
3.3. Synergism of PVA and U0126 on TG cell differentiation and
mineralization
Based on the above results, the possibility that U0126 inhibitor
was able to interact synergistically with PVA substrate to enhance
the differentiation and mineralization of TG cells was tested. Cells
grown on PVA with the addition of 50
m
Mof U0126 were harvested
after 7 days of incubation for analysis of ALP activity and ARS assay.
The results successfully showed that elevation of ALP activity and
mineralization of TG cells on PVA by U0126 treatment, regardless of
using regular or differentiation medium (
Fig. 4
). In addition, the
increasing degree of TG cell differentiation and mineralization
exceeded the effect of PVA and U0126 alone, indicating there was
a significant synergism between PVA and U0126.
3.4. Gene expression of TG cells on PVA and TCPS
In order to examine the synergistic effects between PVA and
U0126 on known mineralization- and differentiation-related
time (day)
ALP activity
(nmol/mg total protein/min)
0
10
20
30
40
50
TCPS
PVA
*
*
*
time (day)
1
7
unit of ARS released
0.0
0.4
0.8
1.2
1.6
2.0
TCPS
PVA
*
*
*
4
1
4
7
a
b
Fig. 2. (a) ALP activity and (b) mineralization (ARS assay) in TG cells cultured on TCPS (closed) and PVA (open) in the regular medium without the addition of dexametha-sone,b-glycerophosphate and ascorbic acid after 1, 4 and 7 days of culture. Results represent the mean SD from 4–5 independent cultures and determinations. Asterisk denotes significant difference (p < 0.005) compared with TCPS, determined by post hoc procedure (Bonferoni analysis).
time (day)
1
ALP activity
(nmol/mg total protein/min)
0
10
20
30
40
50
60
TCPS
PVA
*
*
*
time (day)
1
7
unit of ARS released
0.0
0.4
0.8
1.2
1.6
2.0
TCPS
PVA
*
*
*
7
4
4
a
b
Fig. 1. (a) ALP activity and (b) mineralization (ARS assay) in TG cells cultured on TCPS (closed) and PVA (open) in the differentiation medium after 1, 4 and 7 days of culture. Results represent the mean SD from 2–5 independent cultures and determinations. Asterisk denotes significant difference (p < 0.005) compared with TCPS, determined by post hoc procedure (Bonferoni analysis).
markers, the gene expression of OCN, OPN, DMP 1, and enamelin of
TG cells cultured on TCPS and PVA with or without U0126
treat-ment for 7 days was examined by semi-quantitative RT-PCR (
Fig. 5
).
Compared to TG cells cultured on TCPS without addition of U0126,
exposure of cells to U0126 on TCPS or cells cultured on PVA without
U0126 resulted in an increase in OCN mRNA expression
[25]
,
regardless of the presence or absence of differentiation medium.
When cells cultured on PVA and exposed to U0126, the
combina-tion exhibited a more dramatic effect on increasing transcripts on
OCN. Furthermore, compared to TG cells cultured on TCPS, cells
grown on PVA also exhibited high level of expression of OPN mRNA,
no matter in the regular or the differentiation medium.
Interest-ingly, similar to the effect of PVA, exposure of TG cells to U0126
exhibited an increase expression of OPN mRNA, even cells cultured
on TCPS. This is consistent with the previous report by Higuchi et al.
that cells treated with ERK1/2 inhibitor showed increased levels of
mineralization-related markers
[26]
. In contrast, TG cells cultured
on TCPS, regardless of the presence or absence of U0126, could not
exhibit the expression of DMP 1 and enamelin mRNA, but PVA itself
still induced the mRNA levels for them. DMP 1, a dentin-specific
protein, plays an important role in controlling dentin formation
[27,28]
. Enamelin, a specific protein of enamel matrix and secreted
by ameloblasts, takes part in amelogenesis
[29,30]
. Thus, the
induction of DMP1 and enamelin mRNA further confirmed the
effects of PVA on TG cell differentiation to produce dentin and
enamel mineralization. In addition, the synergistic effects between
PVA and U0126 on expression of DMP1 and enamelin mRNA of TG
cells were still could be detected. Thus, PVA alone or with U0126
inhibitor might be competent to induce the production of desired
factors by activating TG cells.
3.5. Effect of PVA on inhibiting ERK1/2 phosphorylation
Previous studies have demonstrated that the cascade of ERK1/2
pathway can be inhibited by inhibitor, U0126
[7,21]
. Therefore, if
the ERK1/2 pathway is also involved in PVA-promoted TG cell
differentiation and mineralization, it is reasonable to assume that
the ERK1/2 phosphorylation will be reduced or abolished for TG
cells cultured on PVA. Here, we examined the ability of U0126 and
PVA to inhibit ERK1/2 activation of TG cells by
immunocytochem-istry with a widely used phospho-specific ERK1/2 antibody which
recognizes the phosphorylation of the two sites known to be
responsible for the ERK1/2 pathway.
Fig. 6
shows TG cells cultured
on TCPS in the absence of U0126 for 4 h were capable of activating
the ERK1/2 phosphorylation to a high level in Western blot analysis.
Consistent with the effect of ERK1/2 inhibitor, when TG cells
cultured on TCPS for 4 h and then treated with U0126 for 30 min,
the ERK1/2 activity of TG cells was considerably decreased.
ALP activity
(umol/mg total protein/30min)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
*
*
*
0 10 20 50
unit of ARS released
0.0
0.5
1.0
1.5
2.0
2.5
3.0
*
*
*
U0126 ( M)
U0126 ( M)
0 10 20 50
a
b
Fig. 3. Effects of ERK1/2 inhibitor U0126 on (a) ALP activity and (b) mineralization (ARS assay) of TG cells cultured on TCPS in the differentiation medium in a dose-dependent manner on the 7th day of culture. Results represent the mean SD from 4– 5 independent cultures and determinations. Asterisk denotes significant difference (p < 0.005) compared with no inhibition, determined by post hoc procedure (Bonfer-oni analysis).
- + - + -
+
TCPS
differentiation
medium
PVA
differentiation
medium
PVA
regular
medium
TCPS
differentiation
medium
PVA
differentiation
medium
PVA
regular
medium
unit of alizarin red S
released
0.0
0.5
1.0
1.5
2.0
*
*
*
- + - + - +
ALP activity
(umol/mg total protein/30min)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
*
*
*
a
b
U0126 (50 M)
U0126 (50 M)
Fig. 4. Effects of ERK1/2 inhibitor U0126 (50mM) on (a) ALP activity and (b) mineral-ization (ARS assay) of TG cells cultured in the regular or differentiation medium on the 7th day of culture. Results represent the mean SD from 4–5 independent cultures and determinations. Asterisk denotes significant difference (p < 0.005) compared with no inhibition, determined by post hoc procedure (Bonferoni analysis).
Interestingly, TG cells cultured on PVA for 4 h also displayed low
extent of ERK1/2 phosphorylation, while the effect of PVA was not
as stronger as that of U0126. However, synergistic effects between
PVA and U0126 were noted. No levels of ERK1/2 phosphorylation
were detected for TG cells cultured on PVA under the stimulation of
U0126. These results suggested that both U0126 inhibitor and PVA
substrate suppressed the ERK1/2 phosphorylation and the
inacti-vation of ERK1/2 activity helped to induce TG cell differentiation
and mineralization.
To further confirm the role of ERK1/2 activity in TG cell
differ-entiation and mineralization, ERK1/2 activity of TG cells cultured on
TCPS and PVA with differentiation or regular medium was
measured at different time points.
Fig. 7
(a) indicated the level of
ERK1/2 phosphorylation was declined on both TCPS and PVA in the
differentiation medium. Combined with
Fig. 1
, PVA could induce TG
cell differentiation and mineralization, and could inhibit ERK1/2
activation more efficiently than TCPS.
Fig. 7
(b) shows that the ERK1/2
phosphorylation could still be negatively regulated when TG cells
cultured on PVA with regular medium. However, cells cultured on
TCPS without differentiation medium were unable to inhibit ERK1/2
activation, even enhanced ERK1/2 activation. Based on
Figs. 1, 2
and 7
, ERK1/2 phosphorylation negatively regulated ALP activity
and mineralization in TG cells.
4. Discussion
The effects of growth factors
[2]
, cytokines
[3]
, and mechanical
stimulus
[4]
on cell differentiation and mineralization have been
the subject of intense investigation recently. On the other hand, it is
well documented that biomaterials govern cellular responses and
ultimately affect the success of application and, therefore, might be
useful for controlling cell differentiation and mineralization. For
example, neural stem cells respond to different substrates, and
their fate determination depends on the chemical properties of the
substrates
[31]
. In addition, it has been reported that PVA had
a positive effect on HpG2 cell functionality in terms of albumin
synthesis
[32]
.
Traditionally, if cells are able to differentiate toward an
osteo-blast phenotype, culture medium will be routinely added with
dexamethasone,
b
-glycerophosphate and ascorbic acid
[33]
, which
- + - + - + - +
TCPS
PVA
- - + + - - + +
GAPDH
OCN
relative OCN expression
0.0
0.1
0.2
0.3
0.4
0.5
OPN
GAPDH
- + - + - + - +
TCPS
PVA
- - + + - - + +
relative OPN expression
(fold)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
GAPDH
- + - + - + - +
TCPS
PVA
- - + + - - + +
DMP1
relative DMP 1 expression
(fold)
0.00
0.05
0.10
0.15
0.20
0.25
GAPDH
U0126 (50
µµM)
differentiation
medium
U0126 (50
µM)
differentiation
medium
U0126 (50
µM)
differentiation
medium
U0126 (50
µM)
differentiation
medium
- + - + - + - +
TCPS
PVA
- - + + - - + +
Enam
relative enamelin expression
(fold)
0.0
0.1
0.2
0.3
0.4
a
b
c
d
Fig. 5. Effects of ERK1/2 inhibitor U0126 (50mM) on mRNA expression of typical mineralization-related markers in TG cells on the 7th day of culture (a) OCN, (b) OPN, (c) DMP 1 and (d) enamelin. The bar charts show the average density SD of the PCR product from three independent experiments. GAPDH is the normalization control.
had been reported to be beneficial to cell differentiation and
mineralization in the course of culture
[20,33]
. Therefore, ALP
activity and ARS assay of TG cells on TCPS were greatly reduced
with regular medium, when compared with medium containing
differentiation-induced additives (
Figs. 1 and 2
). Interestingly,
compared to TCPS, PVA provided a more preferential environment
for TG cells to express higher levels of the ALP activity and
miner-alization, no matter in the regular or differentiation medium (
Figs. 1
and 2
). These findings suggested that PVA act as an important role
to induce the differentiation and mineralization of TG cells as the
supplement of dexamethasone,
b
-glycerophosphate and ascorbic
acid
[20]
.
Several studies indicated that the MAPK signaling pathway,
particularly through ERK1/2 pathway, plays a critical role in the
regulation of cell growth and differentiation
[21–23]
. However,
there were contradictory results about the relationship between
ERK1/2 phosphorylation and osteoblast differentiation. Kono et al.
[34]
, Higuchi et al.
[26]
and Nakashima et al.
[35]
reported that
ERK1/2 activation negatively regulates the differentiation in
different cells. In contrast, Lai et al.
[36]
demonstrated that ERK1/2
inhibitor suppressed osteoblast differentiation and mineralization.
In order to investigate the direct role of ERK1/2 in the process of TG
cell differentiation and mineralization, cells were treated with
U0126, known to suppress the activation of ERK1/2. Interestingly,
direct suppression of ERK1/2 by U0126 treatment enhanced ALP
activity and mineralization of TG cells grown on TCPS (
Fig. 3
),
indicating a critical involvement of ERK1/2 and acting as a negative
regulator of the differentiation and mineralization of TG cells.
Compared to TCPS, treatment of U0126 further enhanced the ALP
activity and mineralization of TG cells grown on PVA, regardless of
the absence or presence of differentiation medium (
Fig. 4
). In each
case, the increasing expression of ALP activity and ARS assay
exceeded that of PVA or U0126 added alone, indicating that PVA
substrate and U0126 inhibitor synergistically promoted TG cell
differentiation and mineralization. In addition to enhanced ALP
activity and ARS assay, the synergistic effect was further confirmed
by increased expression of OCN, OPN, DMP 1, and enamelin (
Fig. 5
).
These results suggested that TG cells, a heterogeneous population
of cells
[37]
, still had the differentiation and mineralization ability
when they cultured on PVA and treated with U0126.
Based on these results, we focused on defining the specific
signaling pathway involved in PVA-promoted TG cell
differentia-tion and mineralizadifferentia-tion. Direct inhibidifferentia-tion of ERK1/2
phosphoryla-tion by the inhibitor of ERK1/2 U0126 has been related to the
osteoblast differentiation in C2C12 and MC3T3-E1 cells
[32,33]
. In
this study with TG cells, either cells on TCPS treated with U0126 or
on PVA without U0126 treatment inhibited ERK1/2
phosphoryla-tion (
Fig. 6
). Although the effect of PVA was not as stronger as that
of U0126, PVA itself still had the inhibition effect on the activation
of ERK1/2. Furthermore, cells exposed to PVA and U0126 in
combination seemed to exhibit a complete inhibition in ERK1/2
activity when compared with cells exposed to PVA or U0126 alone
(
Fig. 6
). The greater decrease in ERK1/2 activity coincides with the
synergistic effects between PVA and U0126 that TG cells exhibiting
more enhanced ALP activity and ARS assay and more increased
expression of OCN, OPN, DMP 1, and enamelin (
Figs. 4 and 5
).
Analysis of the signaling mechanism responsible for the ability of
PVA to promote differentiation and mineralization of TG cells
identified the ERK1/2 pathway play a direct and critical role, while
neither the p38 nor JNK pathway appeared to be involved (data not
- + - +
U0126 (50
µM)
TCPS
PVA
pERK1/2
ERK1/2
pERK1/2 / ERK1/2
0.0
0.2
0.4
0.6
0.8
Fig. 6. Western blots were performed with phosphorylated ERK1/2 and anti-ERK1/2 antibodies for TG cells cultured on TCPS and PVA in the differentiation medium for 4 h followed by treatment with or without U0126 for 30 min. The upper panel shows the ratio of phosphorylated to total ERK1/2, determined by band densitometry analysis. Results are mean SD from three independent experiments.
pERK1/2 / ERK1/2
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
hours
4 8 12
TCPS
4 8 12
PVA
pERK1/2
ERK1/2
pERK1/2 / ERK1/2
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
pERK1/2
ERK1/2
hours
4 8 12
TCPS
4 8
12
PVA
a
b
Fig. 7. Western blots were performed with phosphorylated ERK1/2 and anti-ERK1/2 antibodies for TG cells on TCPS and PVA in the (a) differentiation and (b) regular medium for 4, 8, and 12 h. The upper panel shows the ratio of phosphorylated to total ERK1/2, determined by band densitometry analysis. Results are mean SD from three independent experiments.
shown). In addition, in comparison with cells cultured on TCPS in
the regular medium, ERK1/2 phosphorylation was reduced in
a time-dependent manner for TG cells cultured on TCPS in the
differentiation medium and on PVA in the regular or differentiation
medium (
Fig. 7
). More importantly, decrease of ERK1/2 activation
was accompanied by an increase in ALP activity and mineralization
(
Figs. 1 and 2
). These results suggest that the ERK1/2 activation
negatively regulates differentiation and mineralization of TG cells
not only cultured on PVA but also treated by U0126. This study
demonstrated a novel role of PVA in promoting the differentiation
and mineralization of TG cells through ERK1/2 acting as a negative
regulator.
5. Conclusion
In summary, the exact regulatory mechanism of differentiation
and mineralization of TG cells by ERK1/2 pathways still remains
unclear. However, we demonstrated that the suppression of ERK1/2
pathway is one of the effects of PVA-promoted TG cell
differenti-ation and mineralizdifferenti-ation. PVA substrate can suppress ERK1/2
acti-vation and exposure of cells to U0126 further improves the
inhibitory effect. The results provide support for the potential
applications of PVA in TG cell investigation and the future
devel-opment of tooth regeneration.
Acknowledgement
The authors thank National Science Council of the Republic of
China for their financial support of this research.
References
[1] Piesco NP, Avery JK. Development of tooth: crown formation. In: Avery JK, Steele PF, Avery NBFA, editors. Oral development and histology. 3rd ed. New York, USA: Thieme Medical Publishers; 2002. p. 72–106.
[2] Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004 Mar;34(3):402–11.
[3] Yang X, Ricciardi BF, Hernandez-Soria A, Shi Y, Camacho NP, Bostrom MPG. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 2007 Dec;41(6):928–36.
[4] Simmons CA, Matlis S, Thornton AJ, Chen SQ, Wang CY, Mooney DJ. Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech 2003 Aug;36(8):1087–96.
[5] Chen RS, Chen YJ, Chen MH, Young TH. Cell–surface interactions of rat tooth germ cells on various biomaterials. J Biomed Mater Res A 2007 Oct;83(1):241–8. [6] Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase
cascades. Adv Cancer Res 1998;74:49–139.
[7] Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999;71(3–4):479–500. [8] Oh CD, Chang SH, Yoon YM, Lee SJ, Lee YS, Kang SS, et al. Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem 2000 Feb 25;275(8):5613–9. [9] Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chon-drogenic ATDC5 cells. J Biol Chem 2001 Apr 27;276(17):14466–73. [10] Stanton LA, Sabari S, Sampaio AV, Underhill TM, Beier F. p38 MAP kinase
signalling is required for hypertrophic chondrocyte differentiation. Biochem J 2004 Feb 15;378(Pt 1):53–62.
[11] Liu HC, Lee IC, Wang JH, Yang SH, Young TH. Preparation of PLLA membranes with different morphologies for culture of MG-63 Cells. Biomaterials 2004 Aug;25(18):4047–56.
[12] Ratisoontorn C, Seto ML, Broughton KM, Cunningham ML. In vitro differenti-ation profile of osteoblasts derived from patients with Saethre-Chotzen syndrome. Bone 2005 Apr;36(4):627–34.
[13] Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998 Jul 17;273(29):18623–32.
[14] Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995 May 8;364(2):229–33.
[15] Bennett BL, Sasaki DT, Murray BW, O’Leary EC, Sakata ST, Xu W, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001 Nov 20;98(24):13681–6.
[16] Bleicher F, Couble ML, Farges JC, Couble P, Magloire H. Sequential expression of matrix protein genes in developing rat teeth. Matrix Biol 1999 Apr;18(2): 133–43.
[17] Kaneda T, Miyauchi M, Takekoshi T, Kitagawa S, Kitagawa M, Shiba H, et al. Characteristics of periodontal ligament subpopulations obtained by sequential enzymatic digestion of rat molar periodontal ligament. Bone 2006 Mar;38(3):420–6.
[18] Yokose S, Kadokura H, Tajima Y, Fujieda K, Katayama I, Matsuoka T, et al. Establishment and characterization of a culture system for enzymatically released rat dental pulp cells. Calcif Tissue Int 2000 Feb;66(2):139–44. [19] Lee DH, Lim BS, Lee YK, Yang HC. Effects of hydrogen peroxide (H2O2) on
alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines. Cell Biol Toxicol 2006 Jan;22(1):39–46.
[20] Cheng SL, Lai CF, Blystone SD, Avioli LV. Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3. J Bone Miner Res 2001 Feb;16(2):277–88.
[21] Julien M, Magne D, Masson M, Rolli-Derkinderen M, Chassande O, Cario-Toumaniantz C, et al. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway. Endocrinology 2007 Feb;148(2):530–7.
[22] Hata K, Ikebe K, Wada M, Nokubi T. Osteoblast response to titanium regulates transcriptional activity of Runx2 through MAPK pathway. J Biomed Mater Res A 2007 May;81(2):446–52.
[23] Lou J, Tu Y, Li S, Manske PR. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 2000 Feb 24;268(3):757–62.
[24] Huang TH, Ding SJ, Hsu TC, Kao CT. Effects of mineral trioxide aggregate (MTA) extracts on mitogen-activated protein kinase activity in human osteosarcoma cell line (U2OS). Biomaterials 2003 Oct;24(22):3909–13.
[25] Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996 Jul 1;317(Pt 1):59–64.
[26] Higuchi C, Myoui A, Hashimoto N, Kuriyama K, Yoshioka K, Yoshikawa H, et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 2002 Oct;17(10):1785–94.
[27] Foster BL, Nociti Jr FH, Swanson EC, Matsa-Dunn D, Berry JE, Cupp CJ, et al. Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcif Tissue Int 2006 Feb;78(2):103–12.
[28] Baba O, Qin C, Brunn JC, Wygant JN, McIntyre BW, Butler WT. Colocalization of dentin matrix protein 1 and dentin sialoprotein at late stages of rat molar development. Matrix Biol 2004 Oct;23(6):371–9.
[29] Sire JY, Davit-Beal T, Delgado S, Gu X. The origin and evolution of enamel mineralization genes. Cells Tissues Organs 2007;186(1):25–48.
[30] Wang HJ, Tannukit S, Zhu DH, Snead ML, Paine ML. Enamel matrix protein interactions. J Bone Miner Res 2005 Jun;20(6):1032–40.
[31] Hung CH, Lin YL, Young TH. The effect of chitosan and PVDF substrates on the behavior of embryonic rat cerebral cortical stem cells. Biomaterials 2006 Sep;27(25):4461–9.
[32] Wang CC, Lu JN, Young TH. The alteration of cell membrane charge after cultured on polymer membranes. Biomaterials 2007 Feb;28(4):625–31. [33] Lee HS, Huang GT, Chiang H, Chiou LL, Chen MH, Hsieh CH, et al.
Multipo-tential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells 2003;21(2):190–9.
[34] Kono SJ, Oshima Y, Hoshi K, Bonewald LF, Oda H, Nakamura K, et al. Erk pathways negatively regulate matrix mineralization. Bone 2007 Jan;40(1): 68–74.
[35] Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, et al. The novel zinc finger-containing transcription factor osterix is required for oste-oblast differentiation and bone formation. Cell 2002 Jan 11;108(1):17–29. [36] Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, et al. Erk is
essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 2001 Apr 27;276(17):14443–50. [37] Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ. Bone
morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res 2002 Aug;17(8): 1441–51.